Document is current
Any future updates will be listed below
-
Authors
Chan, Yan Yi
Ho, Pui Yan
Dib, Carla
Swartzrock, Leah
Rayburn, Maire
Willner, Hana
Ko, Ethan
Ho, Katie
Down, Julian D.
Wilkinson, Adam C.
Nakauchi, Hiro
Denis, Morgane
Cool, Taylor
Czechowicz, Agnieszka https://orcid.org/0000-0003-2909-2669
-
Funding
Funding for this research was provided by:
NIH S10 (1S10RR02933801)
The Taube Stem Cell Pediatric Cancer Research fund
Virginia and D.K. Ludwig Fund for Cancer Research
California Institute for Regenerative Medicine (LA1_C12-06917)
National Institutes of Health (R01DK116944, R01HL147124, R21AG061487)
Japan Society for the Promotion of Science (JSPS20181706)
Stinehart-Reed Foundation
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 6 October 2024
First Online: 29 October 2024
Declarations
:
: Title: Increased understanding of hematopoietic stem cells and their interactions with their microenvironment for enabling improved bone marrow transplantation. Committee name: Stanford University’s Administrative Panel on Laboratory Animal Care (APLAC). Number: 32459. Date of approval: 5/25/2017. All authors confirm their consent for publication.
: A.C. discloses financial interests in the following entities working in the rare genetic disease space: Beam Therapeutics, Decibel Therapeutics, Editas Medicines, GV, Inograft Biotherapeutics, Prime Medicines, and Spotlight Therapeutics. In addition, she is an inventor on patents licensed to Decibel Therapeutics, Editas Medicines, Inograft Biotherapeutics, Jasper Therapeutics, and Magenta Therapeutics.
